{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:29:30Z","timestamp":1794245370873,"version":"4.9.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56347-2","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T14:11:04Z","timestamp":1738764664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche"],"prefix":"10.1038","volume":"16","author":[{"given":"Jayanta","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-1366","authenticated-orcid":false,"given":"Junfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-0640","authenticated-orcid":false,"given":"Jason T.","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-9519","authenticated-orcid":false,"given":"Filippo G.","family":"Giancotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"56347_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","volume":"18","author":"TN Seyfried","year":"2013","unstructured":"Seyfried, T. N. & Huysentruyt, L. C. On the origin of cancer metastasis. Crit. Rev. Oncog. 18, 43\u201373 (2013).","journal-title":"Crit. Rev. Oncog."},{"key":"56347_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares, J. et al. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target. Ther. 5, 28 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"56347_CR3","doi-asserted-by":"crossref","unstructured":"\u0141ukasiewicz, S. et al. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers 13, 4287 (2021).","DOI":"10.3390\/cancers13174287"},{"key":"56347_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","volume":"19","author":"L Jin","year":"2018","unstructured":"Jin, L. et al. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol. Ther. 19, 858\u2013868 (2018).","journal-title":"Cancer Biol. Ther."},{"key":"56347_CR5","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/cam4.1370","volume":"7","author":"W Xiao","year":"2018","unstructured":"Xiao, W. et al. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study. Cancer Med. 7, 922\u2013930 (2018).","journal-title":"Cancer Med."},{"key":"56347_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","volume":"155","author":"FG Giancotti","year":"2013","unstructured":"Giancotti, F. G. Mechanisms governing metastatic dormancy and reactivation. Cell 155, 750\u2013764 (2013).","journal-title":"Cell"},{"key":"56347_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa, M. S., Bragado, P. & Aguirre-Ghiso, J. A. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat. Rev. Cancer. 14, 611\u2013622 (2014).","journal-title":"Nat. Rev. Cancer."},{"key":"56347_CR8","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41556-018-0214-0","volume":"20","author":"ET Goddard","year":"2018","unstructured":"Goddard, E. T. et al. Dormant tumour cells, their niches and the influence of immunity. Nat. Cell Biol. 20, 1240\u20131249 (2018).","journal-title":"Nat. Cell Biol."},{"key":"56347_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini, H. et al. Early dissemination seeds metastasis in breast cancer. Nature 540, 552\u2013558 (2016).","journal-title":"Nature"},{"key":"56347_CR10","doi-asserted-by":"publisher","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin, S. B. & Jones, P. A. Epigenetic determinants of cancer. Cold Spring Harb. Perspect. Biol. 8, a019505 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"56347_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.21037\/atm.2020.02.177","volume":"8","author":"NJ Robinson","year":"2020","unstructured":"Robinson, N. J., Parker, K. A. & Schiemann, W. P. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications. Ann. Transl. Med. 8, 903 (2020).","journal-title":"Ann. Transl. Med."},{"key":"56347_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/2159-8290.CD-21-0010","volume":"11","author":"J Massagu\u00e9","year":"2021","unstructured":"Massagu\u00e9, J. & Ganesh, K. Metastasis-initiating cells and ecosystems. Cancer Discov. 11, 971\u2013994 (2021).","journal-title":"Cancer Discov."},{"key":"56347_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2016.06.009","volume":"166","author":"H Gao","year":"2016","unstructured":"Gao, H. et al. Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling. Cell. 166, 47\u201362 (2016).","journal-title":"Cell."},{"key":"56347_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2012.06.035","volume":"150","author":"H Gao","year":"2012","unstructured":"Gao, H. et al. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 150, 764\u2013779 (2012).","journal-title":"Cell."},{"key":"56347_CR15","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399\u20131405 (1992).","journal-title":"Cancer Res."},{"key":"56347_CR16","doi-asserted-by":"crossref","unstructured":"Kumar, D., et al. LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells. Nat. Cancer 5, 262\u2013282 (2024).","DOI":"10.1038\/s43018-023-00695-9"},{"key":"56347_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/onc.2009.4","volume":"28","author":"D Reisman","year":"2009","unstructured":"Reisman, D., Glaros, S. & Thompson, E. The SWI\/SNF complex and cancer. Oncogene 28, 1653\u20131668 (2009).","journal-title":"Oncogene"},{"key":"56347_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4161\/nucl.26654","volume":"4","author":"P Lu","year":"2013","unstructured":"Lu, P. & Roberts, C. W. The SWI\/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond. Nucleus 4, 374\u2013378 (2013).","journal-title":"Nucleus"},{"key":"56347_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","volume":"11","author":"BG Wilson","year":"2011","unstructured":"Wilson, B. G. & Roberts, C. W. SWI\/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer 11, 481\u2013492 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"56347_CR20","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","volume":"175","author":"N Mashtalir","year":"2018","unstructured":"Mashtalir, N. et al. Modular organization and assembly of SWI\/SNF family chromatin remodeling complexes. Cell 175, 1272\u20131288 (2018).","journal-title":"Cell"},{"key":"56347_CR21","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","volume":"16","author":"TO Nielsen","year":"2010","unstructured":"Nielsen, T. O. et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin. Cancer Res. 16, 5222\u20135232 (2010).","journal-title":"Clin. Cancer Res."},{"key":"56347_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1172\/JCI96153","volume":"128","author":"MB Siegel","year":"2018","unstructured":"Siegel, M. B. et al. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J. Clin. Invest. 128, 1371\u20131383 (2018).","journal-title":"J. Clin. Invest."},{"key":"56347_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cells8040375","volume":"8","author":"NA Riobo-Del Galdo","year":"2019","unstructured":"Riobo-Del Galdo, N. A., Lara Montero, \u00c1. & Wertheimer, E. V. Role of hedgehog signaling in breast cancer: Pathogenesis and therapeutics. Cells. 8, 375 (2019).","journal-title":"Cells."},{"key":"56347_CR24","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature22816","volume":"547","author":"X Ye","year":"2017","unstructured":"Ye, X. et al. Upholding a role for EMT in breast cancer metastasis. Nature 547, E1\u2013E3 (2017).","journal-title":"Nature"},{"key":"56347_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1758834014530023","volume":"6","author":"E Paplomata","year":"2014","unstructured":"Paplomata, E. & O\u2019Regan, R. The PI3K\/AKT\/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther. Adv. Med. Oncol. 6, 154\u2013166 (2014).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"56347_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-484","volume":"14","author":"Q Zhao","year":"2014","unstructured":"Zhao, Q. et al. The clinicopathological significance of neurogenesis in breast cancer. BMC Cancer 14, 484 (2014).","journal-title":"BMC Cancer"},{"key":"56347_CR27","doi-asserted-by":"publisher","first-page":"15978","DOI":"10.3390\/ijms232415978","volume":"23","author":"D Wu","year":"2022","unstructured":"Wu, D., Thompson, L. U. & Comelli, E. M. MicroRNAs: A link between mammary gland development and breast cancer. Int. J. Mol. Sci. 23, 15978 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"56347_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc3078","volume":"11","author":"ET Roussos","year":"2011","unstructured":"Roussos, E. T., Condeelis, J. S. & Patsialou, A. Chemotaxis in cancer. Nat. Rev. Cancer 11, 573\u2013587 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"56347_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V Shankaran","year":"2001","unstructured":"Shankaran, V. et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107\u20131111 (2001).","journal-title":"Nature"},{"key":"56347_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"G Dunn","year":"2002","unstructured":"Dunn, G. et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991\u2013998 (2002).","journal-title":"Nat. Immunol."},{"key":"56347_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/jcb.20645","volume":"97","author":"C Peng","year":"2006","unstructured":"Peng, C. et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J. Cell Biochem. 97, 882\u2013892 (2006).","journal-title":"J. Cell Biochem."},{"key":"56347_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bbrc.2007.04.139","volume":"358","author":"H Sun","year":"2007","unstructured":"Sun, H. et al. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. Biochem. Biophys. Res. Commun. 358, 435\u2013441 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"56347_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112649","volume":"42","author":"A Kharel","year":"2023","unstructured":"Kharel, A. et al. Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer. Cell Rep. 42, 112649 (2023).","journal-title":"Cell Rep."},{"key":"56347_CR34","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.immuni.2023.05.008","volume":"56","author":"AE Baxter","year":"2023","unstructured":"Baxter, A. E. et al. The SWI\/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8+ T cells. Immunity. 56, 1320\u20131340 (2023).","journal-title":"Immunity."},{"key":"56347_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03574-2","volume":"12","author":"L Wei","year":"2021","unstructured":"Wei, L. et al. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-\u03b21\/SMAD2\/3 pathway and ABCC1 transactivation. Cell Death Dis. 12, 334 (2021).","journal-title":"Cell Death Dis."},{"key":"56347_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1053\/j.gastro.2016.06.005","volume":"151","author":"S Heeg","year":"2016","unstructured":"Heeg, S. et al. AK. ETS-Transcription factor ETV1 regulates stromal expansion and metastasis in pancreatic cancer. Gastroenterology 151, 540\u2013553 (2016).","journal-title":"Gastroenterology"},{"key":"56347_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aak9397","volume":"10","author":"Y Okita","year":"2017","unstructured":"Okita, Y. et al. The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB. Sci. Signal. 10, eaak9397 (2017).","journal-title":"Sci. Signal."},{"key":"56347_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2015.109","volume":"35","author":"P Adamo","year":"2016","unstructured":"Adamo, P. & Ladomery, M. The oncogene ERG: a key factor in prostate cancer. Oncogene 35, 403\u2013414 (2016).","journal-title":"Oncogene"},{"key":"56347_CR39","doi-asserted-by":"publisher","first-page":"E3506","DOI":"10.1073\/pnas.1303558110","volume":"110","author":"A Aytes","year":"2013","unstructured":"Aytes, A. et al. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc. Natl. Acad. Sci. USA 110, E3506\u2013E3515 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56347_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/carcin\/bgw121","volume":"38","author":"H Xu","year":"2017","unstructured":"Xu, H., Zhang, Y., Pe\u00f1a, M. M., Pirisi, L. & Creek, K. E. Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages. Carcinogenesis 38, 281\u2013292 (2017).","journal-title":"Carcinogenesis"},{"key":"56347_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.canlet.2017.11.012","volume":"414","author":"S Tomar","year":"2018","unstructured":"Tomar, S. et al. ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase. Cancer Lett. 414, 190\u2013204 (2018).","journal-title":"Cancer Lett."},{"key":"56347_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189050","volume":"1879","author":"M Liu","year":"2024","unstructured":"Liu, M., Hu, W., Meng, X. & Wang, B. TEAD4: A key regulator of tumor metastasis and chemoresistance - Mechanisms and therapeutic implications. Biochim. Biophys. Acta Rev. Cancer 1879, 189050 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"56347_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10585-021-10108-9","volume":"38","author":"J Wutschka","year":"2021","unstructured":"Wutschka, J. et al. JUNB suppresses distant metastasis by influencing the initial metastatic stage. Clin. Exp. Metastasis 38, 411\u2013423 (2021).","journal-title":"Clin. Exp. Metastasis"},{"key":"56347_CR44","doi-asserted-by":"publisher","first-page":"e30506","DOI":"10.7554\/eLife.30506","volume":"6","author":"TWR Kelso","year":"2017","unstructured":"Kelso, T. W. R. et al. Chromatin accessibility underlies synthetic lethality of SWI\/SNF subunits in ARID1A-mutant cancers. Elife. 6, e30506 (2017).","journal-title":"Elife."},{"key":"56347_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14648","volume":"8","author":"BH Alver","year":"2017","unstructured":"Alver, B. H. et al. The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. Nat. Commun. 8, 14648 (2017).","journal-title":"Nat. Commun."},{"key":"56347_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41423-022-00953-3","volume":"20","author":"JA Costoya","year":"2023","unstructured":"Costoya, J. A. & Arce, V. M. Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming. Cell Mol. Immunol. 20, 6\u20137 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"56347_CR47","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.trecan.2020.02.003","volume":"6","author":"J Cao","year":"2020","unstructured":"Cao, J. & Yan, Q. Cancer Epigenetics, Tumor Immunity, and Immunotherapy. Trends Cancer 6, 580\u2013592 (2020).","journal-title":"Trends Cancer"},{"key":"56347_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97390-5","volume":"11","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast. Sci. Rep. 11, 18007 (2021).","journal-title":"Sci. Rep."},{"key":"56347_CR49","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2174\/138955751513150923094709","volume":"15","author":"A Khalid","year":"2015","unstructured":"Khalid, A. et al. Recent advances in discovering the role of CCL5 in metastatic breast cancer. Mini. Rev. Med. Chem. 15, 1063\u20131072 (2015).","journal-title":"Mini. Rev. Med. Chem."},{"key":"56347_CR50","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.20141836","volume":"212","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T. et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J. Exp. Med. 212, 1043\u20131059 (2015).","journal-title":"J. Exp. Med."},{"key":"56347_CR51","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.3390\/ijms21155186","volume":"21","author":"S Kadomoto","year":"2020","unstructured":"Kadomoto, S., Izumi, K. & Mizokami, A. The CCL20-CCR6 Axis in Cancer Progression. Int. J. Mol. Sci. 21, 5186 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"56347_CR52","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3390\/cancers12102884","volume":"12","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. Breast cancer cell-neutrophil interactions enhance neutrophil survival and pro-tumorigenic activities. Cancers 12, 2884 (2020).","journal-title":"Cancers"},{"key":"56347_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add5204","volume":"8","author":"Zheng Gong","year":"2023","unstructured":"Gong, Zheng et al. Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Sci. Immunol. 8, eadd5204 (2023).","journal-title":"Sci. Immunol."},{"key":"56347_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","volume":"39","author":"Y Xiao","year":"2021","unstructured":"Xiao, Y. et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell. 39, 423\u2013437 (2021).","journal-title":"Cancer Cell."},{"key":"56347_CR55","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ccell.2024.05.004","volume":"42","author":"CS McGinnis","year":"2024","unstructured":"McGinnis, C. S. et al. The temporal progression of lung immune remodeling during breast cancer metastasis. Cancer Cell 42, 1018\u20131031 (2024).","journal-title":"Cancer Cell"},{"key":"56347_CR56","doi-asserted-by":"publisher","first-page":"112132","DOI":"10.18632\/oncotarget.22792","volume":"8","author":"J Jablonska","year":"2017","unstructured":"Jablonska, J., Lang, S., Sionov, Vogt & Granot, R. Z. The regulation of pre-metastatic niche formation by neutrophils. Oncotarget. 8, 112132\u2013112144 (2017).","journal-title":"Oncotarget."},{"key":"56347_CR57","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3390\/cancers13236131","volume":"13","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier, C., Simmons, R. L., Tohme, S. & Yazdani, H. O. Neutrophil extracellular traps (NETs) in cancer metastasis. Cancers 13, 6131 (2021).","journal-title":"Cancers"},{"key":"56347_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"56347_CR59","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00262-020-02621-9","volume":"69","author":"JJ Wang","year":"2020","unstructured":"Wang, J. J. et al. Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression. Cancer Immunol. Immunother. 69, 2275\u20132289 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"56347_CR60","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/0008-5472.CAN-21-1012","volume":"82","author":"Jozafina Haj-Shomaly","year":"2022","unstructured":"Haj-Shomaly, J. et al. T Cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy. Cancer Res. 82, 278\u2013291 (2022).","journal-title":"Cancer Res."},{"key":"56347_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110447","volume":"38","author":"K Kos","year":"2022","unstructured":"Kos, K. et al. Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. Cell Rep. 38, 110447 (2022).","journal-title":"Cell Rep."},{"key":"56347_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41423-021-00742-4","volume":"19","author":"LA Huppert","year":"2022","unstructured":"Huppert, L. A. et al. Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy. Cell Mol. Immunol. 19, 33\u201345 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"56347_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02528-8","volume":"22","author":"V Karpisheh","year":"2022","unstructured":"Karpisheh, V. et al. The role of Th17 cells in the pathogenesis and treatment of breast cancer. Cancer Cell Int. 22, 108 (2022).","journal-title":"Cancer Cell Int."},{"key":"56347_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","volume":"522","author":"S Coffelt","year":"2015","unstructured":"Coffelt, S. et al. IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345\u2013348 (2015).","journal-title":"Nature"},{"key":"56347_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972021","volume":"13","author":"DS Kravtsov","year":"2022","unstructured":"Kravtsov, D. S., Erbe, A. K., Sondel, P. M. & Rakhmilevich, A. L. Roles of CD4+ T cells as mediators of antitumor immunity. Front. Immunol. 13, 972021 (2022).","journal-title":"Front. Immunol."},{"key":"56347_CR66","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu, Y. et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat. Med. 29, 1550\u20131562 (2023).","journal-title":"Nat. Med."},{"key":"56347_CR67","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s, F. et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353, 2654\u20132666 (2005).","journal-title":"N. Engl. J. Med."},{"key":"56347_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109118","volume":"35","author":"LS Christian","year":"2021","unstructured":"Christian, L. S. et al. Resident memory T cells in tumor-distant tissues fortify against metastasis formation. Cell Rep. 35, 109118 (2021).","journal-title":"Cell Rep."},{"key":"56347_CR69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"56347_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y., Li, Y. & Zhu, B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 6, e1792 (2015).","journal-title":"Cell Death Dis."},{"key":"56347_CR71","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature16140","volume":"528","author":"SK Wculek","year":"2015","unstructured":"Wculek, S. K. & Malanchi, I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature. 528, 413\u2013417 (2015).","journal-title":"Nature."},{"key":"56347_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick, C. C. & Malanchi, I. Neutrophils in cancer: heterogeneous and multifaceted. Nat. Rev. Immunol. 22, 173\u2013187 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"56347_CR73","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2386","volume":"7","author":"D Jiang","year":"2017","unstructured":"Jiang, D., Saffarzadeh, M. & Scharffetter-Kochanek, K. In vitro demonstration and quantification of neutrophil extracellular trap formation. Bio. Protoc. 7, e2386 (2017).","journal-title":"Bio. Protoc."},{"key":"56347_CR74","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/stem.2417","volume":"34","author":"D Jiang","year":"2016","unstructured":"Jiang, D. et al. Suppression of neutrophil-mediated tissue damage-a novel skill of mesenchymal stem cells. Stem Cells 34, 2393\u20132406 (2016).","journal-title":"Stem Cells"},{"key":"56347_CR75","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1182\/blood-2008-07-171629","volume":"113","author":"CC Yost","year":"2009","unstructured":"Yost, C. C. et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood 113, 6419\u20136427 (2009).","journal-title":"Blood"},{"key":"56347_CR76","doi-asserted-by":"publisher","first-page":"e1000873","DOI":"10.1371\/journal.ppat.1000873","volume":"6","author":"S Bruns","year":"2010","unstructured":"Bruns, S. et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. 6, e1000873 (2010).","journal-title":"PLoS Pathog."},{"key":"56347_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785222","volume":"12","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier, C. et al. Neutrophil extracellular traps promote T cell exhaustion in the tumor microenvironment. Front. Immunol. 12, 785222 (2021).","journal-title":"Front. Immunol."},{"key":"56347_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/imr.13162","volume":"314","author":"S Bert","year":"2023","unstructured":"Bert, S., Nadkarni, S. & Perretti, M. Neutrophil-T cell crosstalk and the control of the host inflammatory response. Immunol. Rev. 314, 36\u201349 (2023).","journal-title":"Immunol. Rev."},{"key":"56347_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y H\u00fcsemann","year":"2008","unstructured":"H\u00fcsemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58\u201368 (2008).","journal-title":"Cancer Cell"},{"key":"56347_CR80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ijms22010173","volume":"22","author":"D Miricescu","year":"2020","unstructured":"Miricescu, D. et al. PI3K\/AKT\/mTOR Signaling pathway in breast cancer: From molecular landscape to clinical aspects. Int. J. Mol. Sci. 22, 173 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"56347_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/carcin\/bgr241","volume":"33","author":"RJ Correa","year":"2012","unstructured":"Correa, R. J., Peart, T., Valdes, Y. R., DiMattia, G. E. & Shepherd, T. G. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis 33, 49\u201358 (2012).","journal-title":"Carcinogenesis"},{"key":"56347_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cai2.10","volume":"1","author":"F Ma","year":"2022","unstructured":"Ma, F. & Xu, B. Expert consensus on the clinical application of PI3K\/AKT\/mTOR inhibitors in the treatment of advanced breast cancer. Cancer Innovation. 1, 25\u201354 (2022).","journal-title":"Cancer Innovation."},{"key":"56347_CR83","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/cam4.833","volume":"5","author":"JG Habib","year":"2016","unstructured":"Habib, J. G. & O\u2019Shaughnessy, J. A. The hedgehog pathway in triple-negative breast cancer. Cancer Med. 5, 2989\u20133006 (2016).","journal-title":"Cancer Med."},{"key":"56347_CR84","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1038\/onc.2011.496","volume":"31","author":"LG Harris","year":"2012","unstructured":"Harris, L. G., Pannell, L. K., Singh, S., Samant, R. S. & Shevde, L. A. Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61. Oncogene. 31, 3370\u20133380 (2012).","journal-title":"Oncogene."},{"key":"56347_CR85","doi-asserted-by":"publisher","first-page":"9589","DOI":"10.1073\/pnas.1017945108","volume":"108","author":"W Chen","year":"2011","unstructured":"Chen, W. et al. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc. Natl. Acad. Sci. USA 108, 9589\u20139594 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56347_CR86","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.celrep.2015.09.063","volume":"13","author":"B Han","year":"2015","unstructured":"Han, B. et al. FOXC1 activates smoothened-independent Hedgehog signaling in basal-like breast cancer. Cell Rep. 13, 1046\u20131058 (2015).","journal-title":"Cell Rep."},{"key":"56347_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana, R. D., Albores-Garc\u00eda, D., Cervantes-Villagrana, A. R. & Garc\u00eda-Acevez, S. J. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct. Target. Ther. 5, 99 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"56347_CR88","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1126\/science.1067431","volume":"296","author":"BS Wiseman","year":"2002","unstructured":"Wiseman, B. S. & Werb, Z. Stromal effects on mammary gland development and breast cancer. Science. 296, 1046\u20131049 (2002).","journal-title":"Science."},{"key":"56347_CR89","doi-asserted-by":"publisher","unstructured":"Garcia-Fabiani, Maria B. et al. \u201cGenetic alterations in gliomas remodel the tumor immune microenvironment and impact immune-mediated therapies.\u201d Front. Oncol. 11, https:\/\/doi.org\/10.3389\/fonc.2021.631037 (2021).","DOI":"10.3389\/fonc.2021.631037"},{"key":"56347_CR90","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00262-006-0164-4","volume":"55","author":"TB Tomasi","year":"2006","unstructured":"Tomasi, T. B., Magner, W. J. & Khan, A. N. H. Epigenetic regulation of immune escape genes in cancer. Cancer Immunol. Immunother. 55, 1159\u20131184 (2006).","journal-title":"Cancer Immunol. Immunother."},{"key":"56347_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844866","volume":"13","author":"BC Taylor","year":"2022","unstructured":"Taylor, B. C. & Balko, J. M. Mechanisms of MHC-I downregulation and role in immunotherapy response. Front. Immunol. 13, 844866 (2022).","journal-title":"Front. Immunol."},{"key":"56347_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy, K., Colbert, J. D. & Rock, K. L. Cancer immune evasion through loss of MHC class I antigen presentation. Front. Immunol. 12, 636568 (2021).","journal-title":"Front. Immunol."},{"key":"56347_CR93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143296","volume":"131","author":"M von Locquenghien","year":"2021","unstructured":"von Locquenghien, M., Rozal\u00e9n, C. & Celi\u00e0-Terrassa, T. Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response. J. Clin. Invest. 131, e143296 (2021).","journal-title":"J. Clin. Invest."},{"key":"56347_CR94","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","volume":"594","author":"AL Correia","year":"2021","unstructured":"Correia, A. L. et al. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature 594, 566\u2013571 (2021).","journal-title":"Nature"},{"key":"56347_CR95","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu, M., Guo, S. & Stiles, J. K. The emerging role of CXCL10 in cancer (Review). Oncol. Lett. 2, 583\u2013589 (2011).","journal-title":"Oncol. Lett."},{"key":"56347_CR96","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/cancers12071765","volume":"12","author":"D Aldinucci","year":"2020","unstructured":"Aldinucci, D., Borghese, C. & Casagrande, N. The CCL5\/CCR5 axis in cancer progression. Cancers 12, 1765 (2020).","journal-title":"Cancers"},{"key":"56347_CR97","doi-asserted-by":"publisher","first-page":"10652","DOI":"10.3390\/ijms241310652","volume":"24","author":"W Liu","year":"2023","unstructured":"Liu, W. et al. CC Chemokine 2 promotes ovarian cancer progression through the MEK\/ERK\/MAP3K19 signaling pathway. Int. J. Mol. Sci. 24, 10652 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"56347_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.972383","volume":"12","author":"J Qiu","year":"2022","unstructured":"Qiu, J. et al. CCL5 mediates breast cancer metastasis and prognosis through CCR5\/Treg cells. Front. Oncol. 12, 972383 (2022).","journal-title":"Front. Oncol."},{"key":"56347_CR99","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nature13862","volume":"515","author":"L Bonapace","year":"2014","unstructured":"Bonapace, L. et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 515, 130\u2013133 (2014).","journal-title":"Nature"},{"key":"56347_CR100","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1189\/jlb.4A1214-603R","volume":"97","author":"R Hwaiz","year":"2015","unstructured":"Hwaiz, R., Rahman, M., Syk, I., Zhang, E. & Thorlacius, H. Rac1-dependent secretion of platelet-derived CCL5 regulates neutrophil recruitment via activation of alveolar macrophages in septic lung injury. J. Leukoc. Biol. 97, 975\u2013984 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"56347_CR101","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura, T., Li, C., Wang, Y. & Matsukawa, A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol. Immunol. 20, 714\u2013738 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"56347_CR102","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1080\/21655979.2021.1977102","volume":"12","author":"LB Kwantwi","year":"2021","unstructured":"Kwantwi, L. B. et al. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer. Bioengineered. 12, 6996\u20137006 (2021).","journal-title":"Bioengineered."},{"key":"56347_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.564169","volume":"8","author":"TM Hofbauer","year":"2020","unstructured":"Hofbauer, T. M. et al. Neutrophil extracellular traps induce MCP-1 at the culprit site in ST-segment elevation myocardial infarction. Front. Cell Dev. Biol. 8, 564169 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"56347_CR104","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood-2013-07-516484","volume":"123","author":"JanM Rossaint","year":"2014","unstructured":"Rossaint, JanM. et al. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap\u2013mediated sterile inflammation. Blood 123, 2573\u20132584 (2014).","journal-title":"Blood"},{"key":"56347_CR105","doi-asserted-by":"publisher","first-page":"361ra138","DOI":"10.1126\/scitranslmed.aag1711","volume":"8","author":"J Park","year":"2016","unstructured":"Park, J. et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci. Transl. Med. 8, 361ra138 (2016).","journal-title":"Sci. Transl. Med."},{"key":"56347_CR106","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues, J. et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361, eaao4227 (2018).","journal-title":"Science"},{"key":"56347_CR107","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12672-024-01010-3","volume":"15","author":"W Jia","year":"2024","unstructured":"Jia, W., Mao, Y., Luo, Q., Wu, J. & Guan, Q. Targeting neutrophil elastase is a promising direction for future cancer treatment. Discov. Oncol. 15, 167 (2024).","journal-title":"Discov. Oncol."},{"key":"56347_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1256360","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer. Front. Oncol. 13, 1256360 (2023).","journal-title":"Front. Oncol."},{"key":"56347_CR109","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.celrep.2016.05.063","volume":"16","author":"A Carugo","year":"2016","unstructured":"Carugo, A. et al. In vivo functional platform targeting patient-derived Xenografts identifies WDR5-Myc association as a critical determinant of pancreatic cancer. Cell Rep. 16, 133\u2013147 (2016).","journal-title":"Cell Rep."},{"key":"56347_CR110","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","volume":"5","author":"C Fellmann","year":"2013","unstructured":"Fellmann, C. et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704\u20131713 (2013).","journal-title":"Cell Rep."},{"key":"56347_CR111","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"56347_CR112","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V61.2.397.397","volume":"61","author":"DL Hines","year":"1983","unstructured":"Hines, D. L. Lipid accumulation and production of colony-stimulating activity by the 266AD cell line derived from mouse bone marrow. Blood 61, 397\u2013402 (1983).","journal-title":"Blood"},{"key":"56347_CR113","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/bioinformatics\/btab711","volume":"38","author":"YR Miao","year":"2022","unstructured":"Miao, Y. R. et al. ImmuCellAI-mouse: a tool for comprehensive prediction of mouse immune cell abundance and immune microenvironment depiction. Bioinformatics 38, 785\u2013791 (2022).","journal-title":"Bioinformatics"},{"key":"56347_CR114","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao, Y. R. et al. ImmuCellAI: A unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv. Sci. 7, 1902880 (2020).","journal-title":"Adv. Sci."},{"key":"56347_CR115","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gyorffy","year":"2021","unstructured":"Gyorffy, B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput. Struct. Biotechnol. J. 19, 4101\u20134109 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"56347_CR116","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.immuni.2015.07.016","volume":"43","author":"J Sheng","year":"2015","unstructured":"Sheng, J., Ruedl, C. & Karjalainen, K. Most tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells. Immunity. 43, 382\u2013393 (2015).","journal-title":"Immunity."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56347-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56347-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56347-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T20:03:58Z","timestamp":1738785838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56347-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56347"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56347-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1378"}}